Effect of thiamine administration on metabolic profile, cytokines and inflammatory markers in drug-naïve patients with type 2 diabetes

European Journal of Nutrition

Volumn 50, Issue 2, 2011, Pages 145-149

  González Ortiz, Manuel ^a   Martínez Abundis, Esperanza ^a   Robles Cervantes, José A ^a   Ramírez Ramírez, Viridiana ^a   Ramos Zavala, Maria G ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Cytokines; Inflammatory markers; Metabolic profile; Thiamine; Type 2 diabetes

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; THIAMINE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; CYTOKINE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INTERVENTION STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METABOLISM; METABOLOME; MIDDLE AGED; PILOT STUDY;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CYTOKINES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; MALE; METABOLOME; MIDDLE AGED; PILOT PROJECTS; THIAMINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79956110219     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-010-0123-x     Document Type: Article

References (15)

1. Blonde L (2007) State of diabetes care in the United States. Am J Manag Care 13(Suppl 2):S36-S40
2. King GL (2008) The role of inflammatory cytokines in diabetes and its complications. J Periodontol 79(Suppl 8):1527-1534
3. Beltramo E, Berrone E, Tarallo S, Porta M (2008) Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta Diabetol 45:131-141
4. Babaei-Jadidi R, Karachalias N, Kupich C, Ahmed N, Thornalley PJ (2004) High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats. Diabetologia 47:2235-2246 (Pubitemid 40174697)
5. Thornalley PJ, Babaei-Jadidi R, Al Ali H, Rabbani N, Antonysunil A, Larkin J, Ahmed A, Rayman G, Bodmer CW (2007) High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 50: 2164-2170 (Pubitemid 47373853)
6. Thornalley PJ (2005) The potential role of thiamine (vitamin B1) in diabetic complications. Curr Diabetes Rev 1:287-298
7. Rabbani N, Alam SS, Riaz S, Larkin JR, Akhatar MW, Shafi T, Thornalley PJ (2009) High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomized, double-blind placebo-controlled pilot study. Diabetologia 52: 208-212
8. Jeyaseelan L, Rao PSS (1989) Methods of determining sample sizes in clinical trials. Indian Pediatr 26:115-121
9. Robles-Cervantes JA, Martínez-Abundis E, González-Ortiz M, Cárdenas-Camarena L, Hernández-Salazar E, Olvera-Ozuna R (2007) Behavior of insulin sensitivity and its relation to leptin and tumor necrosis factor-alpha in obese women undergoing liposuction: 6-month follow-up. Obes Surg 17:1242-1247 (Pubitemid 351321337)
10. Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ (2003) Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 52:2110-2120 (Pubitemid 36919806)
11. Marchetti V, Menghini R, Rizza S, Vivanti A, Feccia T, Lauro D, Fukamizu A, Lauro R, Federici M (2006) Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling. Diabetes 55:2231-2237 (Pubitemid 44743619)
12. Martin SS, Qasim A, Reilly MP (2008) Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 52:1201-1210
13. Schreeb KH, Freudenthaler S, Vormfelde SV, Gundert-Remy U, Gleiter CH (1997) Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate. Eur J Clin Pharmacol 52:319-320 (Pubitemid 27283302)
14. Stirban A, Negrean M, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D (2006) Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 29:2064-2071 (Pubitemid 44871188)
15. Du X, Edelstein D, Brownlee M (2008) Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes. Diabetologia 51:1930-1932